Journal article
How Safe Are COVID-19 Vaccines in Individuals with Immune-Mediated Inflammatory Diseases? The SUCCEED Study
Abstract
We were tasked by Canada's COVID-19 Immunity Task Force to describe severe adverse events (SAEs) associated with emergency department (ED) visits and/or hospitalizations in individuals with immune-mediated inflammatory diseases (IMIDs). At eight Canadian centres, data were collected from adults with rheumatoid arthritis (RA), axial spondyloarthritis (AxS), systemic lupus (SLE), psoriatic arthritis (PsA), and inflammatory bowel disease (IBD). We …
Authors
Tsyruk O; Kaplan GG; Fortin PR; Hitchon CA; Chandran V; Larché MJ; Avina-Zubieta A; Boire G; Colmegna I; Lacaille D
Journal
Vaccines, Vol. 12, No. 9,
Publisher
MDPI
DOI
10.3390/vaccines12091027
ISSN
2076-393X